Adlai Nortye Ltd. ANL

Latest FY: 2025 Healthcare Biotechnology
Market Price $14.72
Market Cap $949.87M
P/E Ratio N/A
Quick Peer Compare (Healthcare):
Revenue (FY 2025) 0.0% YoY
$5.00M
Full year reported
Net Income ↑31.5% YoY
-$35.53M
Net Margin: -710.6%
Free Cash Flow
N/A
FCF Yield: N/A
EPS (Diluted)
N/A
Basic: N/A
Return on Equity Efficiency
N/A
ROA: -177,640.0%
⚡ N/A due to negative equity (share buybacks or other)

📊 Multi-Year Historical Performance & Trends

Financial Performance History Revenue, Net Income & Free Cash Flow
Margins Trend (%) Gross, Operating & Net Margins
Balance Sheet Strength Cash, Debt & Equity
Cash Flow Generation Operating Cash Flow vs CapEx vs FCF

📈 Year-over-Year (YoY) Growth History (ANL)

All monetary values in millions ($M)
Fiscal Year Revenue Revenue YoY Gross Profit Net Income Net Inc YoY Diluted EPS EPS YoY Div / Sh Div Yield Op. Cash Flow Free Cash Flow FCF YoY
FY 2015
FY 2021 $45.7M $45.7M
FY 2022 -100.0% $-58.8M
FY 2023 $5.0M $4.2M $-104.9M -78.4% 0.00%
FY 2024 $5.0M 0.0% $3.1M $-51.9M +50.5% 0.00%
FY 2025 $5.0M 0.0% $3.5M $-35.5M +31.5% 0.00%
$

Valuation

Market Price $14.72
Market Cap $949.87M
Enterprise Value $969.32M
P/E Ratio N/A
P/B Ratio N/A
FCF Yield N/A
Dividend Yield 0.00%
Shares Outstanding 58,734,604
%

Profitability & Margins

Gross Margin 70.24%
Operating Margin 34.06%
Net Margin -710.56%
Return on Equity (ROE) N/A (Negative Equity)
Return on Assets (ROA) -177,640.00%
Asset Turnover 250.00x
Revenue 3-Yr CAGR N/A
🛡️

Financial Health & Liquidity

Current Ratio 0.65
Cash Ratio 0.19
Debt / Equity -3.305
Debt / Assets 1,375.150
Cash & Equivalents $8.06M
Total Debt $27.50M
Book Value / Share $-0.14
💧

Cash Flow Efficiency

Operating Cash Flow N/A
Capital Expenditures (CapEx) $187.00K
Free Cash Flow N/A
OCF / Revenue N/A
FCF / Revenue N/A
FCF 3-Yr CAGR N/A
🏷️

Per Share Metrics

EPS (Diluted) N/A
EPS (Basic) N/A
Dividends / Share N/A
Book Value / Share $-0.14
EPS YoY Growth N/A
🏛️

Balance Sheet (FY 2025)

Total Assets $20.00K
Total Liabilities $8.34M
Stockholders' Equity -$8.32M
Current Assets $26.89M
Current Liabilities $41.63M